1. Home
  2. SPRO vs COE Comparison

SPRO vs COE Comparison

Compare SPRO & COE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.77

Market Cap

135.5M

Sector

Health Care

ML Signal

HOLD

COE

51Talk Online Education Group

HOLD

Current Price

$25.55

Market Cap

140.9M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRO
COE
Founded
2013
2011
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
135.5M
140.9M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
SPRO
COE
Price
$2.77
$25.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
425.0K
7.3K
Earning Date
05-12-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
111.81
N/A
EPS
0.15
N/A
Revenue
$66,802,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$300.00
N/A
P/E Ratio
$18.73
N/A
Revenue Growth
39.24
N/A
52 Week Low
$0.58
$15.32
52 Week High
$3.09
$56.13

Technical Indicators

Market Signals
Indicator
SPRO
COE
Relative Strength Index (RSI) 58.04 59.53
Support Level $2.15 $25.32
Resistance Level $2.88 $27.63
Average True Range (ATR) 0.13 1.85
MACD 0.01 0.44
Stochastic Oscillator 64.04 74.80

Price Performance

Historical Comparison
SPRO
COE

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About COE 51Talk Online Education Group

51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.

Share on Social Networks: